Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Target N. Biotech V currently holds 134,667 shares of Molecular Templates, Inc. (MTEM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Target N. Biotech V has been a net buyer of MTEM stock. They have purchased $56.8M and sold $0 worth of shares.
Target N. Biotech V's most recent insider trade was on Apr 2, 2024, when they purchased 134,667 shares at $2.35 per share.
Target N. Biotech V serves as Executive at Molecular Templates, Inc. (MTEM). They have executed 39 insider transactions totaling $56.8M over their tenure at the company.
Target N. Biotech V holds the position of Executive at Molecular Templates, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 8 years and currently hold a stake valued at $0.
Target N. Biotech V has shown a buying trading pattern, with $56.8M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Target N. Biotech V was on Nov 3, 2020, when they purchased $5.1M worth of ESPR shares. This transaction involved 200,000 shares at $25.31 per share.
Target N. Biotech V currently owns 134,667 shares of Molecular Templates, Inc. (MTEM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Target N. Biotech V's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Target N. Biotech V has 39 Form 4 filings on record as an insider at Molecular Templates, Inc..
Set alerts for Target N. Biotech V and 40,000+ other insiders.